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Angiographic and electronlbeam computed 
tomography studies of retrograde cardioplegia via 
the coronary sinus 
To the Editor: 
We read with great interest he article "Angiographic 
and Electron-Beam Computed Tomography Studies of 
Retrograde Cardioplegia via the Coronary Sinus" au- 
thored by Farge and associates) Since 1993 our labora- 
tory has been addressing the distribution of cardioplegie 
solution delivered via the coronary sinus using explanted 
human hearts. Many of the authors' findings are similar to 
our previously published results; however, there are sig- 
nificant differences that we believe are worthy of discus- 
sion. 
Using their experimental technique, the authors could 
not demonstrate flow to the right ventricular free wall, 
regardless of whether the experimental contrast solution 
was delivered with the coronary sinus occluded at its 
ostium or not. In our article, "Gross and Microvaseular 
Distribution of Retrograde Cardioplegia in Explanted 
Human Hearts, ''2 we found clear anatomic gross and 
mierovaseular histologic evidence for right ventricular f ee 
wall perfusion when cardioplegic solution was delivered 
with the coronary sinus occluded (Fig. 1). In that study we 
used an inert intracapillary marker (NTB-2) to qualita- 
tively examine retrograde distribution. In another manu- 
script, "Coronary Sinus Ostial Occlusion During Retro- 
grade Delivery of Cardioplegic Solution Significantly 
Improves Cardioplegic Distribution and Efficacy, ''3 we 
also found clear evidence of capillary perfusion of right 
ventricular free wall myocardinm. In this experiment 
colored microspheres were added to cardioplegic solution, 
which was delivered retrogradely with the coronary sinus 
either open or occluded, to quantitatively determine 
regional microvascular flow. Right ventricular flow, as well 
as posterior intraventricular septal flow, was greatly aug- 
mented as a result of coronary sinus occlusion. Even 
without occlusion, however, right ventricular flow was 
documented. 
We believe these differing experimental conclusions are 
likely the result of differing experimental models. Flow 
through the coronary venous system and subsequent 
capillary or thebesian systems is governed by the resis- 
tance of the vascular beds and the viscosity of the fluid 
delivered. In our model, explanted human hearts are 
arrested by cold cardioplegia, excised and transferred to 
the laboratory, and subjected to experimental cardioplegic 
solutions within 20 minutes. We believe this model prop- 
erly mimics the clinical situation, and normal operative 
coronary venous vascular resistance is anticipated. The 
authors use cadaveric hearts for experimentation, but they 
do not state how these are obtained and preserved and 
Fig. 1. Transverse section of an explanted human heart 
near the apex after coronary sinus perfusion of the inert 
intravascular marker NTB-2. Note that the material is 
seen in the vasculature of both the left and right ventricles. 
within what time frame they are xamined. Such condi- 
tions, particularly if ischemia is involved, can greatly alter 
vascular resistance. In our microsphere studies, the micro- 
spheres are delivered within human blood cardioplegic 
solution. In our anatomic NTB-2 studies, the experimental 
solution was prepared so that its pH, viscosity, and 
osmolality all resembled blood cardioplegic solution. 
These properties of the authors' experimental solution are 
not mentioned within the article. Such variables, particu- 
larly viscosity, can significantly affect flow. We have found 
that to maintain a coronary sinus pressure of 30 to 40 mm 
Hg, with the coronary sinus occluded, blood cardioplegic 
solution needs to be delivered at a rate of approximately 
0.5 ml/gm of heart tissue per minute. The authors' finding 
of a coronary sinus pressure of 40 mm Hg with a flow rate 
of 100 ml/min suggests either an unusually high vascular 
resistance or very small experimental hearts. Finally, when 
one considers the relative mass differences between the 
left and right ventricles, is it possible that some right 
ventricular perfusion is occurring during these experi- 
ments but that its identification is below the sensitivity of 
electron-beam computed tomography? 
Despite our disagreement regarding right ventricular 
perfusion, this article contains two pieces of anatomic 
information that we have also found to be true. The first 
is the highly variable number of venovenous anastomo- 
ses between veins arising from the coronary sinus (most 
notably, the left anterior descending vein) and the 
posterior descending vein. We believe the quantity and 
quality of these anastomoses determine the amount of 
cardioplegic solution delivered to the posterior intra- 
ventricular septum and right ventricle when a transa- 
trial coronary sinus cannula is being used, whether it is 
The Journal of Thoracic and 
Cardiovascular Surgery 
Volume 114, Number 3 
Letters to the Editor 5 1 9 
a manually inflating or self-inflating cannula. Like the 
authors, we too have found these connections to be 
extremely variable and have noted significant differ- 
ences in right ventricular microvascular flow from one 
heart to another. As such, the surgeon who uses warm 
continuous transatrial retrograde cardioplegia will have 
consequent variable right ventricular protection. This is 
particularly true if cardioplegic flow rates are below 0.5 
ml/gm per minute. Indeed, our initial impetus for 
examining retrograde cardioplegic distribution was a 
poorly protected right ventricle after transatrial warm 
continuous retrograde blood cardioplegia. The second 
important finding in the article is the mean distance of 
just 1.7 _+ 0.6 mm between the coronary sinus ostium 
and the posterior descending vein. Some clinicians have 
suggested that by properly positioning a manually in- 
flating retroperfusion cannula, one can improve car- 
dioplegic distribution to the intraventricular septum 
and right ventricle by direct perfusion of the posterior 
descending vein. In most cases, this is an anatomic 
impossibility. Reliable perfusion of the posterior de- 
scending vein can be achieved only by direct cannula- 
tion of the coronary sinus through an outer purse-string 
suture or by the right atrial isolation approach to 
retrograde cardioplegia delivery. 
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